2026 Health Care Outlook: Ron Piervincenzi, U.S. Pharmacopeia
By Ron Piervincenzi is CEO of U.S. Pharmacopeia.
Latest
Prevention we can afford
This is the third of a three-part op-ed series exploring how simple, affordable prevention could change the trajectory of the opioid epidemic — if we have the will to act.
Holiday Surge: USPS achieves faster deliveries and higher customer approval
Mail items and packages were delivered within 2.5 days on average (16 billion in volume).
Ahold Delhaize USA earns Top Employer certification for 2026
Grocery retailer is recognized for the second consecutive year.
2026 Health Care Outlook: Michael Hogue, APhA
By Michael Hogue, executive vice president and CEO of the American Pharmacists Association
2026 Health Care Outlook: Susan Cantrell, AMCP
By Susan Cantrell, CEO, Academy of Managed Care Pharmacy
2026 Health Care Outlook: Scott Melville, CHPA
By Scott Melville, president and CEO of the Consumer Healthcare Products Association
FMI appoints Jennifer Shawgo as Senior Director, Technology Strategy and Programs
She will help the food industry modernize responsibly by bridging operations, innovation and policy.
2026 Health Care Outlook: Peter Matz, FMI – The Food Industry Association
By Peter Matz, Director of Food, Pharmacy and Health Policy at FMI – The Food Industry Association
Amazon takes aim at Walmart with supersized Chicago big-box store
Amazon plans a nearly 229,000-square-foot superstore in suburban Chicago, surpassing typical Walmart Supercenters and signaling a new phase in its retail strategy.
Kroger announces key leadership changes
“We are excited to promote several talented senior executives to key roles that will position Kroger for future success,” said Ron Sargent, Kroger’s Chairman and CEO.
2026 Health Care Outlook: Chip Davis, HDA
By Chester “Chip” Davis Jr. is president and CEO of the Healthcare Distribution Alliance
Strive sues Eli Lilly and Novo Nordisk over GLP-1 access
Strive Compounding Pharmacy accuses drugmakers of anti-competitive actions to suppress lawful compounded GLP-1 medications and restrict patient choice.
2026 Health Care Outlook: Sheila Arquette, NASP
By Sheila Arquette, president and CEO of the National Association of Specialty Pharmacy
2026 Health Care Outlook: John Murphy III, AAM
By John Murphy III, president and CEO of the Association for Accessible Medicines